Evidence map›Paper›PMID 33477655›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Monosubstituted Acetophenone Thiosemicarbazones as Potent Inhibitors of Tyrosinase: Synthesis, Inhibitory Studies, and Molecular Docking.

Katarzyna Hałdys, Waldemar Goldeman, Natalia Anger-Góra, Joanna Rossowska, Rafał Latajka

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Heliyon · 2023
    Article
  9. Article
  10. Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances.International journal of molecular sciences · 2023
    Review
  11. Article
  12. A potentiometric and spectrofluorimetric approach to unravel inhibitory effects of semi- and thiosemicarbazones on mushroom tyrosinase activity.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katarzyna HałdysDepartment of Bioorganic Chemistry, Wrocław University of Science and Technology, 50-370 Wrocław, Poland.
Waldemar GoldemanDepartment of Organic and Medicinal Chemistry, Wrocław University of Science and Technology, 50-370 Wrocław, Poland.
Natalia Anger-GóraLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Science, 53-114 Wrocław, Poland.ORCID 0000-0003-4942-9134
Joanna RossowskaLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Science, 53-114 Wrocław, Poland.
Rafał LatajkaDepartment of Bioorganic Chemistry, Wrocław University of Science and Technology, 50-370 Wrocław, Poland.
Wrocław University of Science and Technology · PLLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PL

Funding

Krajowy Naukowy Osrodek Wiodacy -Ministerstwo Nauki i Szkolnictwa Wyższego -Wroclawskie Centrum Sieciowo-Superkomputerowe, Politechnika Wroclawska 197
6 · The paper itself

Abstract

A set of 12 monosubstituted acetophenone thiosemicarbazone derivatives (TSCs) were synthesized and their inhibitory properties toward tyrosinase activity were tested. Moreover, their ability to inhibit melanogenesis in the B16F10 murine melanoma cell line was studied. In order to investigate the nature of interactions between the enzyme and the inhibitors, molecular docking to the active site was performed. TSCs 5, 6, 8, and 9 revealed a half maximal inhibitory concentration (IC

Indexed as

kinetic studiesmelanogenesismolecular dockingstructure–activity relationship (SAR)thiosemicarbazonestyrosinase

Identifiers

PMID33477655
PMCPMC7831505
OpenAlexW3125267181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.